Group 1 - Harmony Health Insurance Co., Ltd. plans to reduce its stake in Goldwind Technology by up to 1% during the period from August 1 to October 31, 2025, which amounts to approximately 42.22 million shares [2][4] - The initial reason for the reduction is stated as financial needs of Harmony Health, with an estimated cash realization of about 427 million yuan based on the closing price of 10.11 yuan per share on July 10 [2][4] - This is not the first time Harmony Health has reduced its stake in Goldwind Technology this year, having previously sold over 12.58 million shares between March 17 and April 2 [4][5] Group 2 - As of the latest announcement, Harmony Health holds approximately 474 million shares of Goldwind Technology, representing about 11.21% of the total share capital after excluding shares in the repurchase account [4] - Goldwind Technology is one of the earliest companies in China to enter the wind power equipment manufacturing sector, with main businesses including wind turbine manufacturing, wind power services, and investment in wind farms [4] - The net profit attributable to shareholders of Goldwind Technology is projected to decline by 36.12% and 44.16% in 2022 and 2023, respectively, before a potential increase of 39.78% in 2024 [4] Group 3 - Harmony Health has also reduced its stakes in other A-share companies, including Wanda Information and Guangwei Composite, during the first quarter of this year [6] - The company is undergoing a transformation process to address existing risks and adjust its asset-liability structure, which includes a shift from equity investments to more stable fixed-income products [7][8] - The insurance industry is seeing a trend where approximately 70% of assets are allocated to fixed-income investments, reflecting a broader strategy among insurers to stabilize returns amid market fluctuations [8]